We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 605

Fractured Myriad Genetics ruling follows SCOTUS remand

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • August 30 2012

Ruling that one plaintiff had standing to seek a declaratory judgment as to the patent eligibility of certain genetic discoveries, the Federal Circuit Court of Appeals has once again reversed in part and affirmed in part a lower court’s determination that isolated DNA molecules and methods of comparing molecules to determine whether a patient’s genes have mutations that could cause breast and ovarian cancer were not patent eligible

$10-million prize offered for accurate human genome sequencing

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 3 2011

Craig Venter, creator of rapid DNA sequencing technology, has reportedly told Scientific American that he and two partners will award $10 million to the first team that can meet “medical grade” accuracy in human genome sequencing, a factor that has been lacking since the technology was first developed in 2000

Large pharmaceutical companies look to buy niche Indian biotech firms

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • January 13 2011

Major pharmaceutical companies are reportedly buying niche biotech firms in India to take advantage of emerging opportunities involving biosimilar drugs, which are expected to have a market share of approximately $78 billion by 2013

U.S. Trade Rep launches WTO action against India

  • Shook Hardy & Bacon LLP
  • -
  • India, USA
  • -
  • February 13 2014

U.S. Trade Representative Michael Froman has announced that the United States has requested dispute settlement consultations with India before the

U.S. intervenes in False Claims Act suit against biotech company

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 4 2013

The U.S. government has intervened in part of a False Claims Act (FCA) lawsuit against Agave BioSystems, a biotechnology-based small business with

Consumer-fraud class action filed against 23andme after FDA action

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • December 12 2013

Citing the Food and Drug Administration's (FDA's) November 22, 2013, warning letter, a California resident has filed a putative class action against

“Gray-market” bill targets drug shortages and price gouging

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • June 7 2012

Representative Elijah Cummings (D-Md.) has introduced a bill (H.R. 5853) designed to reform the process in which “gray market” drug companies buy drugs in short supply and then resell them at drastically marked-up prices

News bytes 10 January 2013

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • January 10 2013

The U.S. Patent and Trademark Office (USPTO) schedules an Additive Manufacturing Partnership Meeting on January 23, 2013, at its Alexandria, Virginia

Exhaustion doctrine applied to method patent

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 21 2013

A divided Federal Circuit Court of Appeals panel has determined that a method patent holder that gave away 60 percent of the blood-glucose testing

R&D for new drugs to treat “neglected diseases” continues to lag

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 31 2013

European researchers writing in a medical journal have found that just 4 percent of new therapeutic products registered with drug regulatory